News

Home care agency wins PMD Alliance Parkinson’s accreditation

Angels on Call, a home care services provider, has been granted Certified Parkinson Disease Care (CPDC) accreditation by the Parkinson’s and Movement Disorders Alliance (PMD Alliance). The agency became the first in its field to earn the certification in the U.S. The accreditation involves training staff to…

PNA5 targets Parkinson’s cognitive symptoms, may slow decline

Mice modeling Parkinson’s disease performed better on tests of memory and spatial recognition when given daily under-the-skin injections of PNA5, an experimental ProNeurogen therapy targeting cognitive symptoms — suggesting the treatment’s potential to slow cognitive decline in patients. In this preclinical study, researchers from the University of Arizona…

Texas scientist wins MJFF prize for Parkinson’s research

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) recognized a Texas scientist for his contributions to Parkinson’s research and his commitment to mentoring the next generation of Parkinson’s scientists. Claudio Soto, PhD, a professor of neurology and director of the George and Cynthia Mitchell Center for Alzheimer’s…

Dosing begins in Phase 3 trial of Parkinson’s therapy solengepras

A Phase 3 clinical trial evaluating investigational oral therapy solengepras as a treatment for Parkinson’s disease has dosed its first patient. The ARISE trial (NCT06553027) is evaluating the efficacy of solengepras as a potential add-on therapy to levodopa and other Parkinson’s medications. Patient recruitment is ongoing…